{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T02:07:09Z","timestamp":1774058829181,"version":"3.50.1"},"reference-count":48,"publisher":"Georg Thieme Verlag KG","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thromb Haemost"],"abstract":"<jats:p>Von Willebrand Disease (VWD) is a common inherited bleeding disorder, arising from quantitative or qualitative defects in von Willebrand factor (VWF). Its wide phenotypic variability poses challenges for accurate diagnosis and subtype classification.<\/jats:p>\n                  <jats:p>The B-Will Study is a comprehensive analysis of VWD within the Belgian population, focusing on phenotypic and genotypic characteristics.<\/jats:p>\n                  <jats:p>Patients with suspected VWD were identified from historical records. Extensive laboratory phenotyping, including VWF multimer and genetic analysis, was performed in order to establish definitive VWD classification and subtyping.<\/jats:p>\n                  <jats:p>VWD was confirmed in 511 patients, with type 1 as the predominant subtype, followed by type 2 (especially, 2A\/IIE and 2M-GPIbM). Laboratory phenotype and multimeric pattern were concordant in 75% of 323 cases. Genetic analysis revealed at least one causal variant in 92.7% of patients, uncovering 126 unique variants (58 novel variants). MLPA detected large gene deletions in cases lacking variants by direct sequencing, raising overall variant detection to 93.4%. Phenotype\u2013genotype concordance reached 66% of the 247 fully characterized patients' subgroup.<\/jats:p>\n                  <jats:p>The B-Will Study significantly enhances understanding of VWD in Belgium, demonstrating that integrated phenotypic and genotypic evaluation improves diagnostic accuracy and subtype classification. The established VWD biobank provides a foundation for longitudinal studies, advanced genetic testing, and international collaboration to optimize VWD management.<\/jats:p>","DOI":"10.1055\/a-2829-8877","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T01:21:23Z","timestamp":1774056083000},"source":"Crossref","is-referenced-by-count":0,"title":["Mapping Laboratory Phenotype\u2013Genotype in Von Willebrand Disease: A Belgian National Survey"],"prefix":"10.1055","author":[{"given":"Inge","family":"Vangenechten","sequence":"additional","affiliation":[{"name":"Haemostasis Research Unit, Antwerp University Hospital, Edegem, Belgium"},{"name":"Department of Haematology, Antwerp University Hospital, Edegem, Belgium"},{"name":"Antwerp University, Antwerp, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9v\u00e9rine","family":"De Bruijn","sequence":"additional","affiliation":[{"name":"Haemostasis Research Unit, Antwerp University Hospital, Edegem, Belgium"},{"name":"Department of Haematology, Antwerp University Hospital, Edegem, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2163-8778","authenticated-orcid":false,"given":"Christelle","family":"Orlando","sequence":"additional","affiliation":[{"name":"Department of Hematology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Cauchie","sequence":"additional","affiliation":[{"name":"University Hospital Charleroi-Chimay, Charleroi, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9dric","family":"Hermans","sequence":"additional","affiliation":[{"name":"University Hospital Saint-Luc, Brussels, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Francotte","sequence":"additional","affiliation":[{"name":"Clinique Saint Joseph, Li\u00e8ge, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Agnes","family":"Azerad","sequence":"additional","affiliation":[{"name":"University Hospital Brugmann, Brussels, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Beukinga","sequence":"additional","affiliation":[{"name":"University Hospital Erasme, Brussels, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Gadisseur","sequence":"additional","affiliation":[{"name":"Haemostasis Research Unit, Antwerp University Hospital, Edegem, Belgium"},{"name":"Department of Haematology, Antwerp University Hospital, Edegem, Belgium"},{"name":"Antwerp University, Antwerp, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"issue":"02","key":"ref1","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of the prevalence of Von Willebrand's disease","volume":"69","author":"F Rodeghiero","year":"1987","journal-title":"Blood"},{"issue":"02","key":"ref2","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/blood-2012-01-405134","article-title":"Sequence and structure relationships within Von Willebrand factor","volume":"120","author":"Y F Zhou","year":"2012","journal-title":"Blood"},{"issue":"03","key":"ref3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.blre.2010.03.003","article-title":"The genetic basis of Von Willebrand disease","volume":"24","author":"A C Goodeve","year":"2010","journal-title":"Blood Rev"},{"issue":"10","key":"ref4","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of Von Willebrand disease: a report of the Subcommittee on Von Willebrand Factor","volume":"4","author":"J E Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref5","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/blood-2006-05-020784","article-title":"Phenotype and genotype of a cohort of families historically diagnosed with type 1 Von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 Von Willebrand Disease (MCMDM-1VWD)","volume":"109","author":"A Goodeve","year":"2007","journal-title":"Blood"},{"issue":"02","key":"ref6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1053\/beha.2001.0139","article-title":"Congenital Von Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology","volume":"14","author":"J C Eikenboom","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"issue":"04","key":"ref7","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1538-7836.2006.01847.x","article-title":"A quantitative analysis of bleeding symptoms in type 1 Von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD)","volume":"4","author":"A Tosetto","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"06","key":"ref8","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1182\/blood-2014-08-551960","article-title":"How I treat type 2 variant forms of Von Willebrand disease","volume":"125","author":"A Tosetto","year":"2015","journal-title":"Blood"},{"issue":"S 01","key":"ref9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1538-7836.2011.04324.x","article-title":"Von Willebrand factor: the complex molecular genetics of a multidomain and multifunctional protein","volume":"9","author":"R Schneppenheim","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"S 01","key":"ref10","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.thromres.2007.03.014","article-title":"Von Willebrand disease - phenotype versus genotype: deficiency versus disease","volume":"120","author":"D Lillicrap","year":"2007","journal-title":"Thromb Res"},{"issue":"19","key":"ref11","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1182\/blood-2011-06-360875","article-title":"Intersection of mechanisms of type 2A VWD through defects in VWF multimerization, secretion, ADAMTS-13 susceptibility, and regulated storage","volume":"119","author":"P M Jacobi","year":"2012","journal-title":"Blood"},{"issue":"01","key":"ref12","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","article-title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of Von Willebrand disease","volume":"5","author":"P D James","year":"2021","journal-title":"Blood Adv"},{"issue":"08","key":"ref13","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.jtha.2024.05.006","article-title":"Application of genetic testing for the diagnosis of Von Willebrand disease","volume":"22","author":"O Seidizadeh","year":"2024","journal-title":"J Thromb Haemost"},{"issue":"13","key":"ref14","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1182\/blood-2014-08-528398","article-title":"Diagnostic approach to Von Willebrand disease","volume":"125","author":"C Ng","year":"2015","journal-title":"Blood"},{"issue":"01","key":"ref15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41572-024-00536-8","article-title":"Von Willebrand disease","volume":"10","author":"O Seidizadeh","year":"2024","journal-title":"Nat Rev Dis Primers"},{"issue":"01","key":"ref16","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1182\/asheducation-2016.1.670","article-title":"What have we learned from large population studies of Von Willebrand disease?","volume":"2016","author":"R R Montgomery","year":"2016","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"issue":"05","key":"ref17","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/jcp.46.5.470","article-title":"Analysis of Von Willebrand factor multimers using a commercially available enhanced chemiluminescence kit","volume":"46","author":"A M Cumming","year":"1993","journal-title":"J Clin Pathol"},{"issue":"02","key":"ref18","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1055\/s-0038-1645215","article-title":"Luminographic detection of Von Willebrand factor multimers in agarose gels and on nitrocellulose membranes","volume":"63","author":"U Budde","year":"1990","journal-title":"Thromb Haemost"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/978-1-4939-7196-1_36","article-title":"Laboratory testing for Von Willebrand factor multimers","volume":"1646","author":"S Oliver","year":"2017","journal-title":"Methods Mol Biol"},{"issue":"06","key":"ref20","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/rth2.12408","article-title":"Improving diagnosis of Von Willebrand disease: reference ranges for Von Willebrand factor multimer distribution","volume":"4","author":"I Vangenechten","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"issue":"03","key":"ref21","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1160\/TH08-08-0500","article-title":"Rapid molecular diagnosis of Von Willebrand disease by direct sequencing. Detection of 12 novel putative mutations in VWF gene","volume":"101","author":"I Corrales","year":"2009","journal-title":"Thromb Haemost"},{"issue":"23","key":"ref23","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1182\/blood-2009-07-226324","article-title":"A cluster of mutations in the D3 domain of Von Willebrand factor correlates with a distinct subgroup of Von Willebrand disease: type 2A\/IIE","volume":"115","author":"R Schneppenheim","year":"2010","journal-title":"Blood"},{"issue":"01","key":"ref24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/j.seminhematol.2004.10.002","article-title":"Phenotypic and genotypic diagnosis of Von Willebrand disease: a 2004 update","volume":"42","author":"R Schneppenheim","year":"2005","journal-title":"Semin Hematol"},{"issue":"02","key":"ref25","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1053\/beha.2001.0134","article-title":"A molecular approach to the classification of Von Willebrand disease","volume":"14","author":"R Schneppenheim","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"issue":"04","key":"ref26","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/1076029606293422","article-title":"Classification and characterization of hereditary types 2A, 2B, 2C, 2D, 2E, 2M, 2N, and 2U (unclassifiable) Von Willebrand disease","volume":"12","author":"J J Michiels","year":"2006","journal-title":"Clin Appl Thromb Hemost"},{"issue":"01","key":"ref27","first-page":"96","article-title":"Von Willebrand disease type 2A phenotypes IIC, IID and IIE: a day in the life of shear-stressed mutant Von Willebrand factor","volume":"112","author":"M A Brehm","year":"2014","journal-title":"Thromb Haemost"},{"issue":"11","key":"ref28","doi-asserted-by":"crossref","first-page":"e3038","DOI":"10.1097\/MD.0000000000003038","article-title":"A laboratory phenotype\/genotype correlation of 1167 French patients from 670 families with Von Willebrand disease: a new epidemiologic picture","volume":"95","author":"A Veyradier","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"13","key":"ref29","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1182\/bloodadvances.2022007216","article-title":"Phenotypic and genetic characterizations of the Milan cohort of Von Willebrand disease type 2","volume":"6","author":"O Seidizadeh","year":"2022","journal-title":"Blood Adv"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/978-1-4939-7196-1_35","article-title":"Ristocetin-induced platelet aggregation (RIPA) and RIPA mixing studies","volume":"1646","author":"J P Frontroth","year":"2017","journal-title":"Methods Mol Biol"},{"issue":"06","key":"ref31","doi-asserted-by":"crossref","first-page":"e0179566","DOI":"10.1371\/journal.pone.0179566","article-title":"Type 2B Von Willebrand disease with or without large multimers: a distinction of the two sides of the disorder is long overdue","volume":"12","author":"A Casonato","year":"2017","journal-title":"PLoS One"},{"issue":"01","key":"ref32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1182\/blood.V68.1.149.149","article-title":"A new Von Willebrand variant (type I, New York): increased ristocetin-induced platelet aggregation and plasma Von Willebrand factor containing the full range of multimers","volume":"68","author":"H J Weiss","year":"1986","journal-title":"Blood"},{"issue":"04","key":"ref33","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/hae.12117","article-title":"Variability in platelet- and collagen-binding defects in type 2M Von Willebrand disease","volume":"19","author":"D M Larsen","year":"2013","journal-title":"Haemophilia"},{"issue":"01","key":"ref34","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/ajh.24556","article-title":"Utility of the Von Willebrand factor collagen binding assay in the diagnosis of Von Willebrand disease","volume":"92","author":"E J Favaloro","year":"2017","journal-title":"Am J Hematol"},{"issue":"02","key":"ref35","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1053\/beha.2001.0137","article-title":"Type 2 Von Willebrand disease causing defective Von Willebrand factor-dependent platelet function","volume":"14","author":"D Meyer","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"issue":"03","key":"ref36","first-page":"848","article-title":"Ser968Thr mutation within the A3 domain of Von Willebrand factor (VWF) in two related patients leads to a defective binding of VWF to collagen","volume":"86","author":"A S Ribba","year":"2001","journal-title":"Thromb Haemost"},{"issue":"06","key":"ref37","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/j.1538-7836.2010.03869.x","article-title":"Absent collagen binding in a VWF A3 domain mutant: utility of the VWF:CB in diagnosis of VWD","volume":"8","author":"V H Flood","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"05","key":"ref38","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1055\/s-0036-1579641","article-title":"Type 2M and type 2A Von Willebrand disease: similar but different","volume":"42","author":"E J Favaloro","year":"2016","journal-title":"Semin Thromb Hemost"},{"issue":"02","key":"ref39","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1053\/beha.2001.0138","article-title":"Type 2N Von Willebrand disease: clinical manifestations, pathophysiology, laboratory diagnosis and molecular biology","volume":"14","author":"C Mazurier","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"issue":"05","key":"ref40","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1172\/JCI116443","article-title":"Von Willebrand factor mutation enhancing interaction with platelets in patients with normal multimeric structure","volume":"91","author":"L Holmberg","year":"1993","journal-title":"J Clin Invest"},{"issue":"01","key":"ref41","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1182\/asheducation-2014.1.524","article-title":"Clinical and laboratory diagnosis of VWD","volume":"2014","author":"A B Federici","year":"2014","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"issue":"01","key":"ref42","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1182\/blood-2006-05-021105","article-title":"The mutational spectrum of type 1 Von Willebrand disease: results from a Canadian cohort study","volume":"109","author":"P D James","year":"2007","journal-title":"Blood"},{"issue":"04","key":"ref43","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/bjh.13064","article-title":"The diagnosis and management of Von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology","volume":"167","author":"M A Laffan","year":"2014","journal-title":"Br J Haematol"},{"issue":"12","key":"ref44","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.3324\/haematol.2017.168765","article-title":"Molecular and clinical profile of Von Willebrand disease in Spain (PCM-EVW-ES): comprehensive genetic analysis by next-generation sequencing of 480 patients","volume":"102","author":"N Borr\u00e0s","year":"2017","journal-title":"Haematologica"},{"issue":"05","key":"ref45","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.jtha.2023.01.012","article-title":"Genetic determinants of enhanced Von Willebrand factor clearance from plasma","volume":"21","author":"O Seidizadeh","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"04","key":"ref46","doi-asserted-by":"crossref","first-page":"e335","DOI":"10.1055\/s-0042-1757635","article-title":"Analysis of Von Willebrand Disease in the \u201cHeart of Europe.\u201d","volume":"6","author":"I Vangenechten","year":"2022","journal-title":"TH Open"},{"issue":"01","key":"ref47","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41525-023-00375-8","article-title":"Population-based prevalence and mutational landscape of Von Willebrand disease using large-scale genetic databases","volume":"8","author":"O Seidizadeh","year":"2023","journal-title":"NPJ Genom Med"},{"issue":"07","key":"ref48","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3324\/haematol.2011.055285","article-title":"High-throughput molecular diagnosis of Von Willebrand disease by next generation sequencing methods","volume":"97","author":"I Corrales","year":"2012","journal-title":"Haematologica"},{"issue":"01","key":"ref49","first-page":"17","article-title":"Genotype-phenotype correlation in a cohort of Portuguese patients comprising the entire spectrum of VWD types: impact of NGS","volume":"116","author":"T Fidalgo","year":"2016","journal-title":"Thromb Haemost"}],"container-title":["Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2829-8877.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T01:21:29Z","timestamp":1774056089000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2829-8877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":48,"URL":"https:\/\/doi.org\/10.1055\/a-2829-8877","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0340-6245","2567-689X"],"issn-type":[{"value":"0340-6245","type":"print"},{"value":"2567-689X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]}}}